Katharine D Maglione1, Amie Y Lee2, Kimberly M Ray2, Bonnie N Joe2, Ronald Balassanian3. 1. 1 Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY. 2. 2 Department of Radiology and Biomedical Imaging, University of California San Francisco School of Medicine, 1600 Divisadero St, San Francisco, CA 94115. 3. 3 Department of Pathology, University of California San Francisco, San Francisco, CA.
Abstract
OBJECTIVE: The majority of MRI-guided breast biopsies yield benign pathology. The purpose of this article is to provide a comprehensive overview of benign pathologic entities commonly encountered at MRI-guided breast biopsy. CONCLUSION: Proper radiologic-pathologic correlation is an integral component of MRI-guided breast biopsy. Familiarity with the spectrum of MRI findings and key histopathologic features of common benign entities will enhance the radiologist's confidence in determining concordance and lead to improved patient management recommendations.
OBJECTIVE: The majority of MRI-guided breast biopsies yield benign pathology. The purpose of this article is to provide a comprehensive overview of benign pathologic entities commonly encountered at MRI-guided breast biopsy. CONCLUSION: Proper radiologic-pathologic correlation is an integral component of MRI-guided breast biopsy. Familiarity with the spectrum of MRI findings and key histopathologic features of common benign entities will enhance the radiologist's confidence in determining concordance and lead to improved patient management recommendations.
Authors: Beatriz E Adrada; Mary S Guirguis; Tuan Hoang; David A Spak; Gaiane M Rauch; Tanya W Moseley Journal: Radiographics Date: 2022-02-04 Impact factor: 5.333